Drug
Who makes efavirenz, lamivudine and tenofovir disoproxil fumarate?
2 companies list efavirenz, lamivudine and tenofovir disoproxil fumarate as a human prescription drug, including under the names SYMFI. Forms: tablet, film coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing efavirenz, lamivudine and tenofovir disoproxil fumarate
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| LAURUS LABS LIMITEDIndia | tablet, film coated | ANDAANDA212786, ANDA213038 | 2 | 5 |
| Viatris Inc.India | tablet, film coated | NDANDA022142 | 1 | 18 |
Enquiry
Common questions
- Who makes efavirenz, lamivudine and tenofovir disoproxil fumarate?
- 2 companies list efavirenz, lamivudine and tenofovir disoproxil fumarate as a human prescription drug in the openFDA NDC Directory, led by LAURUS LABS LIMITED, Viatris Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic SYMFI?
- 1 company lists efavirenz, lamivudine and tenofovir disoproxil fumarate under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.